XLRN - Acceleron Pharma Inc
Previous close
178.75
0 0%
Share volume: 0
Last Updated: Fri 19 Nov 2021 06:00:00 AM CET
Biological Product (except Diagnostic) Manufacturing :
-4.32%
PREVIOUS CLOSE
CHG
CHG%
$178.75
0.00
0.00%
Summary score
20%
Profitability
18%
Dept financing
12%
Liquidity
75%
Performance
10%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2017 - 30-Jun-2021
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.61%
Return on assets
-7.28%
Return on sales
-614.32%
Return on invested capital
-43.24%
Total debt ratio
7.95%
Debt ratio change over timeo
-1.09%
Current Ratio
17.34%
Quick Ratio
17.06%
Cash Position Ratio
16.19%
Short-term ratios 30-Jun-2020 - 30-Jun-2021
The data are presented for the financials results of the quarters of the last year.
Return on equity
-6.81%
Return on assets
-6.3%
Return on sales
-220.32%
Return on invested capital
319.11%
Total debt ratio
7.5%
Debt ratio change over timeo
-1.11%
Current Ratio
16.55%
Quick Ratio
16.55%
Cash Position Ratio
15.51%
Last quarter ratios 30-Jun-2021
The data are presented for the financials results of the last quarter.
Return on equity
-8.32%
Return on assets
-7.61%
Return on sales
-227.85%
Return on invested capital
-108.03%
Total debt ratio
8.73%
Debt ratio change over time
-1.08%
Current Ratio
12.07%
Quick Ratio
12.07%
Cash Position Ratio
10.48%
Performance ratios (change over 4 years) 30-Jun-2017 - 30-Jun-2021
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-91.08%
Return on assets
-91.39%
Return on sales
787.8%
Return on invested capital
-166.88%
Total debt ratio
-108.78%
Debt ratio change over time
-1.09%
Current Ratio
-20.62%
Quick Ratio
-19.71%
Cash Position Ratio
-19.29%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XLRN | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -7.61% | -0.85% | -12.72% | 0% |
| Return on assets | -7.28% | -1.73% | -10.89% | 0% |
| Return on sales | -614.32% | -23.52% | 0% | 0% |
| Return on invested capital | -43.24% | 10.77% | -27.16% | 0% |
| Profitability | 0% | 25% | 25% | 50% |
| Total debt ratio | 7.95% | 16.42% | 15.85% | 0% |
| Debt ratio change over time | -1.09% | -2.05% | -1.6% | 0% |
| Dept financing | 12% | 25% | 24% | 25% |
| Current Ratio | 16.55% | 6.66% | 0% | 0% |
| Quick Ratio | 16.55% | 6.36% | 0% | 0% |
| Cash Position Ratio | 15.51% | 5.07% | 0% | 0% |
| Liquididy | 75% | 16% | 10% | 0% |
| Short-term ratios | XLRN | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -6.81% | 6.73% | 0% | 0% |
| Return on assets | -6.3% | 5% | 0% | 0% |
| Return on sales | -220.32% | 6.9% | 0% | 0% |
| Return on invested capital | 319.11% | 60.51% | 0% | 0% |
| Profitability | 25% | 80% | 0% | 0% |
| Total debt ratio | 7.5% | 16.25% | 0% | 0% |
| Debt ratio change over time | -1.11% | -2.65% | 0% | 0% |
| Dept financing | 12% | 25% | 25% | 0% |
| Current Ratio | 16.55% | 6.66% | 0% | 0% |
| Quick Ratio | 16.55% | 6.36% | 0% | 0% |
| Cash Position Ratio | 15.51% | 5.07% | 0% | 0% |
| Liquididy | 75% | 28% | 0% | 0% |